FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis

American Journal of Roentgenology

Volumn 194, Issue 1, 2010, Pages 231-236

  Prakash, Priyanka ^a   Kalra, Mannudeep K ^b   Sharma, Amita ^b   Shepard, Jo Anne O ^b   Digumarthy, Subba R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Chest; PET CT; Pulmonary lymphangitic carcinomatosis

Indexed keywords

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOLOGIST; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IOPAMIDOL; LUNG NEOPLASMS; LYMPHANGITIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 74749108016     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3059     Document Type: Article

References (15)

1. Meerbeeck JP, Gosselin R, Duyck P. Lung metastases: epidemiology, clinical presentation and imaging In: Van Schil P, ed. Lung metastases and isolated lung perfusion. New York, NY: Nova Science Publishers, 2007:3-25
2. Herold CJ, Bankier AA, Fleischmann D. Lung metastases. Eur Radiol 1996; 6:596-606
3. Davis SD. CT evaluation for pulmonary metastasis in patients with extrathoracic malignancy. Radiology 1991; 180:1-12
4. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526-533
5. Shim SS, Lee KS, Kim B, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2005; 236:1011-1019
6. Digumarthy SR. Fischman AJ, Kwek BH, Aquino SL. Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis. J Comput Assist Tomogr 2005; 29:346-349
7. Acikgoz G, Kim SM, Houseni M, Cermik TF, Intenzo CM, Alavi A. Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings. Clin Nucl Med 2006; 31:673-678
8. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-fluorine-[18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850
9. 18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med 1996; 23:517-523
10. Masson RG, Krikorian J, Lukl P, et al. Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med 1989; 321:71-76
11. Soares FA, Pinto AP, Landell GA, et al. Pulmonary tumor embolism to arterial vessels and carcinomatous lymphangitis: a comparative clinicopathological study. Arch Pathol Lab Med 1993; 117:827-831
12. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171:111-116
13. Stein MG, Mayo J, Muller N, et al. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987; 162:371-375
14. Johkoh T, Ikezoe J, Tomiyama N, et al. CT findings in lymphangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests. AJR 1992; 158:1217-1222
15. Munk PL, Muller NL, Miller RR, Ostrow DN. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 1988; 166:705-709